Company INTEGRATE

INTP

US45818D1081

Pharmaceuticals

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Business description: INTEGRATE

Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.

Executive Committee: INTEGRATE

Manager	Title	Age	Since
Brad Nightingale PSD	President	56	-
Luke Zouvas LAW	General Counsel	-	-

See INTEGRATE governance

Company details: INTEGRATE

Integrated Pharmaceuticals, Inc.

5727 East Canyon Ridge North Drive

85331, Cave Creek

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTEGRATE	-.--%	-.--%	-	-	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	+1.81%	+2.25%	+13.40%	+84.45%	48B
OTSUKA HOLDINGS CO., LTD.	-2.54%	+3.72%	+65.71%	+113.61%	36.89B
CIPLA LIMITED	+0.15%	+1.26%	-3.35%	+45.56%	12.37B
ZYDUS LIFESCIENCES LIMITED	+3.71%	+3.56%	+14.13%	+97.20%	11.95B
KRKA, D. D.	+0.39%	+0.58%	+33.25%	+119.07%	9.01B
GEDEON RICHTER	+0.66%	-0.57%	+19.28%	+45.55%	7.2B
ONO PHARMACEUTICAL CO., LTD.	+0.71%	+1.75%	+53.59%	-7.09%	7.05B
GLENMARK PHARMACEUTICALS LIMITED	+0.68%	+2.63%	+23.97%	+235.28%	6.55B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+9.99%	+32.94%	-15.69%	+27.08%	6.58B
Average	+1.56%	+3.82%	+22.70%	+84.52%	14.56B
Weighted average by Cap.	+0.84%	+3.35%	+27.92%	+89.56%